MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Spero Therapeutics (SPRO) Ownership - Who owns Spero Therapeutics?

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
25
Web
https://www.sperotherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
172.55M
P/E Ratio
11.04
Total Cash
48.62M
Projected Growth
N/A
Total Debt
3.35M
Revenue
29.32M
Risk (Beta)
3.78
Dividend Yield
N/A
Total Cash/Share
0.84
Total Debt/Equity
N/A
Revenue/Share
0.92 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SPRO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SPRO
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
25
Web
https://www.sperotherapeutics.com